Investigating the source and the action behind shunt obstruction in the treatment of pediatric hydrocephalus
Investigating the source and the action behind shunt obstruction in the treatment of pediatric hydrocephalus
批准号:
10660190
负责人:
Carolyn A Harris
金额:
$57.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-06-01 至 2028-05-31
关键词:
AddressAreaAstrocytesAttenuatedAwarenessBiochemicalBiological FactorsBiomedical EngineeringBiometryBrainCaringCathetersCell Culture TechniquesCell-Matrix JunctionCellsCephalicCerebral VentriclesCerebrospinal FluidChemicalsChildhoodClinicalClinical DataCorrelation StudiesDataDevicesDiagnosisDiseaseDrainage procedureEpendymaEtiologyEventFailureFutureGenetic DiseasesGoalsGrowthHydrocephalusIn VitroInflammatoryLiquid substanceLocationMacrophageMagnetic Resonance ImagingMeasurementMeasuresMechanicsMeningitisMinorModelingModificationNatural ImmunityNeuroendoscopyNeurogliaNeurologicNeurologic DeficitNeurosurgeonObstructionPatient CarePatientsPatternPerformancePersonsPharmaceutical PreparationsPhysiologicalPrevention strategyProcessProductionProliferatingPublishingQuality of lifeRecordsReportingShunt DeviceSourceStrokeStructure of choroid plexusSubarachnoid HemorrhageSurfaceSystemTLR4 geneTestingThickTimeTissuesTraumatic Brain InjuryTreatment ProtocolsUnited StatesVariantVentricularabsorptionbiobankcell growthcerebrospinal fluid flowclinically relevantclinically significantcommon treatmentcytokinedesignexperienceimprovedin vitro Modelindividualized medicineinterdisciplinary approachmigrationneurophysiologypatient populationpatient subsetspressurepreventresponsetumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Hydrocephalus, an imbalance between cerebrospinal fluid production and absorption, is diagnosed in
more than 1 in 500 people in the United States. Approximately 80% of these patients will suffer long-term
neurological deficits. Genetic diseases, meningitis, subarachnoid hemorrhage, stroke, traumatic brain injury, or
tumors cause hydrocephalus. The common treatment for all hydrocephalus patients is CSF drainage by
shunting. Despite all our efforts, shunts still have the highest failure rate of any neurological device. A
shocking 85% of shunts fail after just ten years. Failed shunts are plagued with astrocytes and macrophages,
but we still do not understand the process by which these cells are pulled in, migrate, and grow.
In our first aim, we identify what patient conditions contribute to tissue contact and what variables
trigger tissue pull in into shunt catheter holes. We clearly define physical variables that create instances of
tissue pull in using computational fluid dynamics and a benchtop model (“Brain on a Bench”). We continue the
use of this system in Aims 2 and 3. In this way, we investigate what single or repetitive events cause shunt
catheter contact and tissue pull in with the ventricular wall, parenchyma, or choroid plexus.
In our second aim, we determine if cell growth is a necessary component to shunt obstruction after
contact with a tissue source occurs. We examine the growth, proliferation, and activation state of the cells
following single or repetitive contact with ventricular wall, parenchyma, and choroid plexus just as we did in
Aim 1.
In our final aim, we use our heightened awareness of tissue pull in and tissue growth to understand
how changes to shunt design can influence shunt obstruction. We prioritize the clinical conditions shown to
exacerbate tissue contact and test under physical variables that show direct pull in and growth of ventricular
wall, parenchyma, and choroid plexus.
In summary: our patient data informs us of the patient conditions that correlate to contact of ventricular
wall, parenchyma, and choroid plexus. Benchtop and computational fluid dynamics models prioritize these
environmental conditions while systematically testing what variables cause tissue pull in and growth. Strategies
to prevent obstruction by inhibition of pull in and growth are tailored for ideal performance under the conditions
set by our patient and benchtop data. Altogether, these data improve our mechanistic understanding of shunt
obstruction necessary to and narrow our area of focus for improved treatment of hydrocephalus.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Avoiding the pocket: A case report of coiling of distal shunt catheter into subcutaneous pocket.
避免口袋:远端分流导管卷入皮下口袋的病例报告。
DOI:
10.1016/j.ijscr.2017.09.036
发表时间:
2017
期刊:
International journal of surgery case reports
影响因子:
0.6
作者:
[Garling,RichardJustin, Sood,Sandeep, Harris,CarolynAnne]
通讯作者:
Harris,CarolynAnne
DOI:
10.1371/journal.pone.0294811
发表时间:
2023
期刊:
PloS one
影响因子:
3.7
作者:
[]
通讯作者:
DOI:
10.3171/2020.6.peds20454
发表时间:
2021-02-01
期刊:
Journal of neurosurgery. Pediatrics
影响因子:
--
作者:
[Zahedi S, Hudson M, Jin X, Garling RJ, Gluski J, Nowak C, Marupudi NI, Begeman P, Harris CA]
通讯作者:
Harris CA
Response of Astrocytes to Blood Exposure due to Shunt Insertion in vitro.
星形胶质细胞对体外分流插入引起的血液暴露的反应。
DOI:
10.1002/aic.17485
发表时间:
2021
期刊:
AIChE journal. American Institute of Chemical Engineers
影响因子:
--
作者:
[Zaranek,Mira, Arshad,Rooshan, Zheng,Kevin, Harris,CarolynA]
通讯作者:
Harris,CarolynA
DOI:
10.1039/d0ra05128d
发表时间:
2020
期刊:
RSC advances
影响因子:
3.9
作者:
[Horbatiuk J, Alazzawi L, Harris CA]
通讯作者:
Harris CA
共 12 条
Omniphobic Cerebral Shunt to Eliminate Clogging and Dysfunction
-
批准号:10490443
-
项目类别:
-
资助金额:$49.74万
-
财政年份:2018
-
负责人:Carolyn A Harris
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: